Missing/wrong data?
Log in to edit
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase
scientific article
Author/s
author: Hagop Kantarjian, Srdan Verstovsek, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Jorge Eduardo Cortes, Naveen Pemmaraju, Naval Daver, Talha Badar
Work details
Publication date
June 11, 2015
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.